Ria. J Neurol 2012;259:2429433. Greenberg SM, Vernooij MW, Cordonnier C, et al. Cerebral microbleeds: a guide to detection and interpretation. Lancet Neurol 2009;8:16574. Feldman HH, Maia LF, Mackenzie IR, Forster BB, Martzke J, Woolfenden A. Superficial siderosis: a prospective diagnostic marker of cerebral amyloid angiopathy in Alzheimer illness. Stroke 2008;39:2894897. Wardlaw JM, Smith EE, Biessels GJ, et al. Neuroimaging standards for analysis into little vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol 2013;12:82238. Zhu YC, Tzourio C, Soumare A, Mazoyer B, Dufouil C, Chabriat H. Severity of dilated Virchow-Robin spaces is connected with age, blood pressure, and MRI markers of compact vessel disease: a population-based study. Stroke 2010;41:2483490. Charidimou A, Boulouis G, Haley K, et al. White matter hyperintensity patterns in cerebral amyloid angiopathy and hypertensive arteriopathy. Neurology 2016;86:50511. Foster-Dingley JC, Moonen JE, van den Berg-Huijsmans AA, et al. Reduced blood stress and gray matter integrity loss in older persons. J Clin Hypertens 2015;17:63037. Reijn TS, Rikkert MO, van Geel WJ, de Jong D, Verbeek MM. Diagnostic accuracy of ELISA and xMAP technology for evaluation of amyloid beta(42) and tau proteins. Clin Chem 2007;53:85965.19.20.21.22.23.24.25.26.27.28.29.30.31.32.33.34.Tarasoff-Conway JM, Carare RO, Osorio RS, et al. Clearance systems inside the brain: implications for Alzheimer illness. Nat Rev Neurol 2015;11:45770. Attems J, Jellinger K, Thal DR, Van Nostrand W. Assessment: sporadic cerebral amyloid angiopathy. Neuropathol Appl Neurobiol 2011;37:753. Weller RO, Subash M, Preston SD, Mazanti I, Carare RO. Perivascular drainage of amyloid-beta peptides from the brain and its failure in cerebral amyloid angiopathy and Alzheimer’s illness. Brain Pathol 2008;18:25366. Zhang-Nunes SX, Maat-Schieman ML, van Duinen SG, Roos RA, Frosch MP, Greenberg SM. The cerebral beta-amyloid angiopathies: hereditary and sporadic. Brain Pathol 2006;16:309. Shinkai Y, Yoshimura M, Ito Y, et al. Amyloid beta-proteins 1-40 and 1-42(43) inside the soluble fraction of extra- and intracranial blood vessels. Ann Neurol 1995;38:42128. Natte R, Yamaguchi H, Maat-Schieman ML, et al. Ultrastructural evidence of early non-fibrillar Abeta42 inside the capillary basement membrane of patients with hereditary cerebral hemorrhage with amyloidosis, Dutch kind. Acta Neuropathol 1999;98:57782. Alonzo NC, Hyman BT, Rebeck GW, Greenberg SM. Progression of cerebral amyloid angiopathy: accumulation of amyloid-beta40 in affected vessels. J Neuropathol Exp Neurol 1998;57:35359. Maat-Schieman ML, van Duinen SG, Rozemuller AJ, Haan J, Roos RA. Association of vascular amyloid beta and cells of your mononuclear phagocyte program in hereditary cerebral hemorrhage with amyloidosis (Dutch) and Alzheimer illness.PFKM Protein Purity & Documentation J Neuropathol Exp Neurol 1997;56: 27384.IL-21R, Mouse (217a.a, HEK293, His) Vinters HV, Secor DL, Read SL, et al.PMID:23514335 Microvasculature in brain biopsy specimens from sufferers with Alzheimer’s disease: an immunohistochemical and ultrastructural study. Ultrastruct Pathol 1994;18:33348. Herzig MC, Van Nostrand WE, Jucker M. Mechanism of cerebral beta-amyloid angiopathy: murine and cellular models. Brain Pathol 2006;16:404. Lopera F, Ardilla A, Martinez A, et al. Clinical characteristics of early-onset Alzheimer illness within a significant kindred with an E280A presenilin-1 mutation. JAMA 1997;277:79399. Bateman RJ, Xiong C, Benzinger TL, et al. Clinical and biomarker changes in dominantly.
